A
Albireo Pharma Inc
F:BDQM
Albireo Pharma Inc
F:BDQM
Price:
41.41
EUR
0.46%
Market Cap:
€857.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
A
|
Amneal Pharmaceuticals Inc
F:2DT
|
US |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
CN |
|
Miricor Enterprises Holdings Ltd
HKEX:1827
|
HK |
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BDQM.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BDQM
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
BDQM Competitors Multiples
Albireo Pharma Inc Competitors
Albireo Pharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Albireo Pharma Inc
F:BDQM
|
856.9m EUR | 17.6 | -7.7 | -6.4 | -6.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 109.7 | -1 713.1 | 15 914.4 | -1 797 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.7 | 29.3 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
